Publications by authors named "Eva Ramos"

Claim this Profile
P
Physical fitness and cardiac function in childhood cancer survivors.
Pedro L Valenzuela, Javier S Morales, Elena Santana-Sosa, Blanca Herrero Velasco, Antonio Baño-Rodrigo, Eva S C Ramos

J Sci Med Sport· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological evaluation of non-nucleotide purine derivatives as P2X7 antagonists for the treatment of neuroinflammation in traumatic brain injury.
Inés Valencia, Andrea Pastor-Martínez, Céline Decouty-Pérez, Ana Belen Lopez-Rodriguez, María Álvarez-Rubal, Eva Ramos

Br J Pharmacol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In Vivo Evidence of Melatonin's Protective Role in Alkylating-Agent-Induced Pulmonary Toxicity: A Systematic Review.
Emma Sola, Jose A Morales-García, Francisco López-Muñoz, Eva Ramos, Alejandro Romero

Antioxidants (Basel)· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oxidative and Molecular-Structural Alterations of Spermatozoa in Swine and Ram Exposed to the Triazole Ipconazole.
Cristian Falero, Wilfredo Huanca, Luis Barrios-Arpi, Boris Lira-Mejía, Olger Ramos-Coaguila, Eva Ramos, Mariella Ramos-Gonzalez

Toxics· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential of melatonin to reverse epigenetic aberrations in oral cancer: new findings.
Emilio Gil-Martín, Eva Ramos, Francisco López-Muñoz, Javier Egea, Alejandro Romero

EXCLI J· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-Excitatory Amino Acids, Melatonin, and Free Radicals: Examining the Role in Stroke and Aging.
Victoria Jiménez Carretero, Eva Ramos, Pedro Segura-Chama, Adan Hernández, Andrés M Baraibar

Antioxidants (Basel)· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Redox Regulation of Microglial Inflammatory Response: Fine Control of NLRP3 Inflammasome through Nrf2 and NOX4.
Alejandra Palomino-Antolín, Céline Decouty-Pérez, Víctor Farré-Alins, Paloma Narros-Fernández, Ana Belen Lopez-Rodriguez, Eva Ramos

Antioxidants (Basel)· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
C-glycosides analogues of the okadaic acid central fragment exert neuroprotection via restoration of PP2A-phosphatase activity: A rational design of potential drugs for Alzheimer's disease targeting tauopathies.
Raquel L Arribas, Lucía Viejo, Isaac Bravo, Minerva Martínez, Eva Ramos

Eur J Med Chem· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic Potential of Melatonin Counteracting Chemotherapy-Induced Toxicity in Breast Cancer Patients: A Systematic Review.
Eva Ramos, Javier Egea, Francisco López-Muñoz, Emilio Gil-Martín, Alejandro Romero

Pharmaceutics· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Melatonin: a multitasking indoleamine to modulate hippocampal neurogenesis.
Alejandro Romero, José Ángel Morales-García, Eva Ramos

Neural Regen Res· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Melatonin as Modulator for Sulfur and Nitrogen Mustard-Induced Inflammation, Oxidative Stress and DNA Damage: Molecular Therapeutics.
Eva Ramos, Emilio Gil-Martín, Cristóbal De Los Ríos, Javier Egea, Francisco López-Muñoz

Antioxidants (Basel)· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coronavirus Disease 2019 (COVID-19) and Its Neuroinvasive Capacity: Is It Time for Melatonin?
Alejandro Romero, Eva Ramos, Francisco López-Muñoz, Emilio Gil-Martín, Germaine Escames

Cell Mol Neurobiol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and Pharmacological Evaluation of New -Sulfonylureas as NLRP3 Inflammasome Inhibitors: Identification of a Hit Compound to Treat Gout.
Paloma Narros-Fernández, Mourad Chioua, Sonia A Petcu, Daniel Diez-Iriepa, Laura Cerrada-Gálvez, Eva Ramos

J Med Chem· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Coronavirus Disease 2019 (COVID-19): Key Emphasis on Melatonin Safety and Therapeutic Efficacy.
Eva Ramos, Francisco López-Muñoz, Emilio Gil-Martín, Javier Egea, Iris Álvarez-Merz

Antioxidants (Basel)· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In Silico Prediction of the Toxic Potential of Neuroprotective Bifunctional Molecules Based on Chiral -Propargyl-1,2-amino Alcohol Derivatives.
Eva Ramos, Rocío Lajarín-Cuesta, Raquel L Arribas, Eva M García-Frutos, Laura González-Lafuente

Chem Res Toxicol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toxicology of Blister Agents: Is Melatonin a Potential Therapeutic Option?
Alejandro Romero, Eva Ramos, Francisco López-Muñoz, Cristóbal De Los Ríos, Javier Egea

Diseases· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Melatonin Reduces NLRP3 Inflammasome Activation by Increasing α7 nAChR-Mediated Autophagic Flux.
Víctor Farré-Alins, Paloma Narros-Fernández, Alejandra Palomino-Antolín, Céline Decouty-Pérez, Ana Belen Lopez-Rodriguez, Eva Ramos

Antioxidants (Basel)· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
and ADME-Tox Profiling and Safety Significance of Multifunctional Monoamine Oxidase Inhibitors Targeting Neurodegenerative Diseases.
Anna Więckowska, Natalia Szałaj, Izabella Góral, Adam Bucki, Gniewomir Latacz, Eva Ramos

ACS Chem Neurosci· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Melatonin's efficacy in stroke patients; a matter of dose? A systematic review.
Eva Ramos, Víctor Farré-Alins, Javier Egea, Francisco López-Muñoz, Russel J Reiter

Toxicol Appl Pharmacol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Highlights of ASS234: a novel and promising therapeutic agent for Alzheimer's disease therapy.
Alejandro Romero, José Marco-Contelles, Eva Ramos

Neural Regen Res· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New flavonoid - ,-dibenzyl(-methyl)amine hybrids: Multi-target-directed agents for Alzheimer´s disease endowed with neurogenic properties.
Martín Estrada-Valencia, Clara Herrera-Arozamena, Concepción Pérez, Dolores Viña, José A Morales-García, Eva Ramos

J Enzyme Inhib Med Chem· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential of Melatonin as Adjuvant Therapy of Oral Cancer in the Era of Epigenomics.
Ana Capote-Moreno, Eva Ramos, Javier Egea, Francisco López-Muñoz, Emilio Gil-Martín

Cancers (Basel)· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
QuinoxalineTacrine QT78, a Cholinesterase Inhibitor as a Potential Ligand for Alzheimer's Disease Therapy.
Eva Ramos, Alejandra Palomino-Antolín, Manuela Bartolini, Isabel Iriepa, Ignacio Moraleda

Molecules· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Melatonin: A hypothesis for Kawasaki disease treatment.
Eva Ramos, Paloma Patiño, Russel J Reiter, Emilio Gil-Martín, Francisco López-Muñoz

Med Hypotheses· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modulation of Heat Shock Response Proteins by ASS234, Targeted for Neurodegenerative Diseases Therapy.
Eva Ramos, Alejandro Romero, José Marco-Contelles, Francisco López-Muñoz, Javier Del Pino

Chem Res Toxicol· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis